Under the terms of the agreement, NextGen shareholders will receive $23.95 in cash for each share they own. The deal was unanimously approved by NextGen’s board of directors, according to a Sept. 6 NextGen news release.
The transaction is expected to be completed in the fourth calendar quarter of 2023.
“NextGen Healthcare’s mission-critical EMR software and surrounding solutions are the backbone of ambulatory practices across the United States,” A.J. Rohde, a senior partner at Thoma Bravo, said in the release. “We are so proud to be working with NextGen Healthcare in its next phase as a private company and look forward to continued product innovation to better support NextGen Healthcare’s thousands of highly-valued customers.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.